| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +1,016,812 | 78% | $52.08 | +$52,954,466 |
| Sells | 5 | -292,407 | 22% | $56.74 | -$16,590,174 |
| Net | -2 | +724,405 | 55% | +$36,364,292 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Simeon George | Director | $90,021,213 | +$51,499,918 | +134% | 16 Jul 2025 |
| Rodger Novak | President, Director | $35,814,599 | 30 Jun 2021 | ||
| Samarth Kulkarni | Chief Executive Officer, Director | $12,572,943 | -$12,715,825 | -50% | 20 Jan 2026 |
| Bradley J. Bolzon PhD | Director | $9,302,369 | 09 Jun 2022 | ||
| JAMES R. KASINGER | General Counsel and Secretary | $5,554,573 | -$991,714 | -15% | 13 Oct 2025 |
| Tony W. Ho | Executive VP, Head of R&D | $3,272,902 | 03 Dec 2021 | ||
| Lawrence Otto Klein | Cbo & Coo | $1,674,890 | 16 Aug 2022 | ||
| Douglas A. Treco | Director | $1,254,660 | +$1,140,600 | +1000% | 06 Aug 2025 |
| Julianne Bruno | Chief Operating Officer | $726,967 | -$147,301 | -17% | 20 Mar 2025 |
| Raju Prasad | Chief Financial Officer | $407,464 | -$2,594,019 | -86% | 06 Jan 2026 |
| Brendan Smith | Chief Financial Officer | $317,015 | 18 Feb 2023 | ||
| John Greene | Director | $313,948 | +$313,948 | 05 Jun 2025 | |
| Phuong Khanh Morrow | Chief Medical Officer | $275,700 | 13 Oct 2023 | ||
| Naimish Patel | Chief Medical Officer | $218,083 | -$141,316 | -39% | 03 Oct 2025 |
| Briggs Morrison | Director | $195,806 | 05 Jun 2025 | ||
| MICHAEL JOHN TOMSICEK | Chief Financial Officer | $118,193 | 06 Aug 2021 | ||
| Maria Fardis | Director | 05 Jun 2025 | |||
| Katherine A. High | Director | 05 Jun 2025 | |||
| Harold Edward Fleming | Director | 05 Jun 2025 | |||
| Christian Rommel | Director | 05 Jun 2025 | |||
| Ali Behbahani | Director | 05 Jun 2025 | |||
| Sandesh Mahatme | Director | 05 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|